AMPK-mTORC1 pathway mediates hepatic IGFBP-1 phosphorylation in glucose deprivation

Jenica H. Kakadia,Muhammad U. Khalid,Ilka U. Heinemann,Victor Han
DOI: https://doi.org/10.1530/jme-23-0137
2024-01-10
Journal of Molecular Endocrinology
Abstract:Mechanisms underlying limitations in glucose supply that restrict fetal growth are not well established. IGF-1 is an important regulator of fetal growth and IGF-1 bioavailability is markedly inhibited by IGFBP-1 especially when the binding protein is hyperphosphorylated. We hypothesized that the AMPK-mTORC1 pathway increases IGFBP-1 phosphorylation in response to glucose deprivation. Glucose deprivation in HepG2 cells activated AMPK and TSC2, inhibited mTORC1 and increased IGFBP-1 secretion and site-specific phosphorylation. Glucose deprivation also decreased IGF-1 bioavailability and IGF-dependent activation of IGF-1R. AICAR (an AMPK-activator) activated TSC2, inhibited mTORC1 and increased IGFBP-1 secretion/ phosphorylation. Further, siRNA silencing of either AMPK or TSC2 prevented mTORC1 inhibition and IGFBP-1 secretion and phosphorylation in glucose deprivation. Our data suggest that the increase in IGFBP-1 phosphorylation in response to glucose deprivation is mediated by the activation of AMPK/TSC2 and inhibition of mTORC1, providing a possible mechanistic link between glucose deprivation and restricted fetal growth.
endocrinology & metabolism
What problem does this paper attempt to address?